Last reviewed · How we verify
SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
SARS-CoV-2 vaccination: Comirnaty or Vaxzevria is a Biologic drug developed by University of Melbourne. It is currently in Phase 2 development.
At a glance
| Generic name | SARS-CoV-2 vaccination: Comirnaty or Vaxzevria |
|---|---|
| Sponsor | University of Melbourne |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection
- Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity (PHASE2)
- Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia) (PHASE3)
- Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
- Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria CI brief — competitive landscape report
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria updates RSS · CI watch RSS
- University of Melbourne portfolio CI
Frequently asked questions about SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
What is SARS-CoV-2 vaccination: Comirnaty or Vaxzevria?
SARS-CoV-2 vaccination: Comirnaty or Vaxzevria is a Biologic drug developed by University of Melbourne.
Who makes SARS-CoV-2 vaccination: Comirnaty or Vaxzevria?
SARS-CoV-2 vaccination: Comirnaty or Vaxzevria is developed by University of Melbourne (see full University of Melbourne pipeline at /company/university-of-melbourne).
What development phase is SARS-CoV-2 vaccination: Comirnaty or Vaxzevria in?
SARS-CoV-2 vaccination: Comirnaty or Vaxzevria is in Phase 2.